Skip to main content
Erschienen in: Journal of Assisted Reproduction and Genetics 9/2017

29.06.2017 | Reproductive Physiology and Disease

The anti-Müllerian hormone (AMH) induces forkhead box L2 (FOXL2) expression in primary culture of human granulosa cells in vitro

verfasst von: Sandro Sacchi, Federica Marinaro, Susanna Xella, Tiziana Marsella, Daniela Tagliasacchi, Antonio La Marca

Erschienen in: Journal of Assisted Reproduction and Genetics | Ausgabe 9/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Anti-Müllerian hormone (AMH) and forkhead box L2 (FOXL2) are two pivotal genes expressed in human granulosa cells (hGCs) where both genes share similar inhibitory functions on activation and follicular growth in order to preserve the ovarian follicle reserve. Furthermore, AMH and FOXL2 contribute to inhibit steroidogenesis, decreasing or preventing the activation of gonadotrophin-dependent aromatase CYP19A1 cytochrome P450 family 19 subfamily A member 1 (CYP19A1). The purpose of this study is to evaluate the role of AMH in regulating the expression of FOXL2.

Methods

Primary cultures of hGCs were treated with increasing concentrations of recombinant human AMH (rhAMH; range 10–100 ng/ml) for 3 h. Negative controls were performed using corresponding amounts of AMH vehicle. Total RNA or proteins were purified and quantified by spectrophotometry. FOXL2 and CYP19A1 gene expression, normalized by reference gene ribosomal protein S7 (RpS7), was evaluated by RT-qPCR. Each reaction was repeated in triplicate. Statistical analysis was performed. Extracted proteins were analyzed by immunoblot using anti-FOXL2 and anti-β-actin as primary antibodies.

Results

rhAMH treatments tested did not modulate the basal expression of aromatase CYP19A1 gene. rhAMH (50 ng/ml) was able to increase FOXL2 gene expression and its intracellular content.

Conclusions

This study demonstrated the existence of an AMH-FOXL2 relationship in hGCs. AMH is capable of increasing both gene and protein expression of FOXL2. Because FOXL2 induces AMH transcription, these ovarian factors could be finely regulated by a positive feedback loop mechanism to preserve the ovarian follicle reserve.
Literatur
1.
Zurück zum Zitat Visser JA, de Jong FH, Laven JSE, Themmen APN. Anti-Mullerian hormone: a new marker for ovarian function. Reproduction. 2006;131(1):1–9.CrossRefPubMed Visser JA, de Jong FH, Laven JSE, Themmen APN. Anti-Mullerian hormone: a new marker for ovarian function. Reproduction. 2006;131(1):1–9.CrossRefPubMed
2.
Zurück zum Zitat Durlinger AL, Visser JA, Themmen APN. Regulation of ovarian function: the role of anti-Müllerian hormone. Reproduction. 2002;124(5):601–9.CrossRefPubMed Durlinger AL, Visser JA, Themmen APN. Regulation of ovarian function: the role of anti-Müllerian hormone. Reproduction. 2002;124(5):601–9.CrossRefPubMed
3.
Zurück zum Zitat Choi Y. A Rajkovic. Genetics of early mammalian folliculogenesis. Cell Mol Life Sci. 2006;63(5):579–90.CrossRefPubMed Choi Y. A Rajkovic. Genetics of early mammalian folliculogenesis. Cell Mol Life Sci. 2006;63(5):579–90.CrossRefPubMed
4.
Zurück zum Zitat Depmann M, Faddy MJ, van der Schouw YT, Peeters PHM, Broer SL, Kelsey TW, et al. The relation between variation in size of the primordial follicle pool and age at natural menopause. J Clin Endocrinol Metab. 2015;100(6):E845–51.CrossRefPubMed Depmann M, Faddy MJ, van der Schouw YT, Peeters PHM, Broer SL, Kelsey TW, et al. The relation between variation in size of the primordial follicle pool and age at natural menopause. J Clin Endocrinol Metab. 2015;100(6):E845–51.CrossRefPubMed
5.
Zurück zum Zitat Nilsson E, Rogers N, Skinner MK. Actions of anti-Mullerian hormone on the ovarian transcriptome to inhibit primordial to primary follicle transition. Reproduction. 2007;134(2):209–21.CrossRefPubMed Nilsson E, Rogers N, Skinner MK. Actions of anti-Mullerian hormone on the ovarian transcriptome to inhibit primordial to primary follicle transition. Reproduction. 2007;134(2):209–21.CrossRefPubMed
6.
Zurück zum Zitat Dunlop CE, Anderson RA. The regulation and assessment of follicular growth. Scand J Clin Lab Invest Suppl. 2014;244:13–7. discussion 17CrossRefPubMed Dunlop CE, Anderson RA. The regulation and assessment of follicular growth. Scand J Clin Lab Invest Suppl. 2014;244:13–7. discussion 17CrossRefPubMed
7.
Zurück zum Zitat Kerr JB, Myers M, Anderson RA. The dynamics of the primordial follicle reserve. Reproduction. 2013;146(6):R205–15.CrossRefPubMed Kerr JB, Myers M, Anderson RA. The dynamics of the primordial follicle reserve. Reproduction. 2013;146(6):R205–15.CrossRefPubMed
8.
Zurück zum Zitat Sacchi S, D’Ippolito G, Sena P, Marsella T, Tagliasacchi D, Maggi E, et al. The anti-müllerian hormone (AMH) acts as a gatekeeper of ovarian steroidogenesis inhibiting the granulosa cell response to both FSH and LH. J Assist Reprod Genet. 2016;33(1):95–100.CrossRefPubMed Sacchi S, D’Ippolito G, Sena P, Marsella T, Tagliasacchi D, Maggi E, et al. The anti-müllerian hormone (AMH) acts as a gatekeeper of ovarian steroidogenesis inhibiting the granulosa cell response to both FSH and LH. J Assist Reprod Genet. 2016;33(1):95–100.CrossRefPubMed
9.
Zurück zum Zitat Pellatt L, Rice S, Dilaver N, Heshri A, Galea R, Brincat M, et al. Anti-Mullerian hormone reduces follicle sensitivity to follicle-stimulating hormone in human granulosa cells. Fertil Steril. 2011;96(5):1246–51.CrossRefPubMed Pellatt L, Rice S, Dilaver N, Heshri A, Galea R, Brincat M, et al. Anti-Mullerian hormone reduces follicle sensitivity to follicle-stimulating hormone in human granulosa cells. Fertil Steril. 2011;96(5):1246–51.CrossRefPubMed
10.
Zurück zum Zitat van Houten EL, Themmen AP, Visser JA. Anti-Müllerian hormone (AMH): regulator and marker of ovarian function. Ann Endocrinol (Paris). 2010;71(3):191–7.CrossRef van Houten EL, Themmen AP, Visser JA. Anti-Müllerian hormone (AMH): regulator and marker of ovarian function. Ann Endocrinol (Paris). 2010;71(3):191–7.CrossRef
11.
Zurück zum Zitat Visser JA, Themmen APN. Role of anti-Müllerian hormone and bone morphogenetic proteins in the regulation of FSH sensitivity. Mol Cell Endocrinol. 2014;382(1):460–5.CrossRefPubMed Visser JA, Themmen APN. Role of anti-Müllerian hormone and bone morphogenetic proteins in the regulation of FSH sensitivity. Mol Cell Endocrinol. 2014;382(1):460–5.CrossRefPubMed
12.
Zurück zum Zitat Chang HM, Klausen C, Leung PCK. Antimullerian hormone inhibits follicle stimulating hormone-induced adenylyl cyclase activation, aromatase expression, and estradiol production in human granulosa-lutein cells. Fertil Steril. 2013;100(2):585–92.CrossRefPubMed Chang HM, Klausen C, Leung PCK. Antimullerian hormone inhibits follicle stimulating hormone-induced adenylyl cyclase activation, aromatase expression, and estradiol production in human granulosa-lutein cells. Fertil Steril. 2013;100(2):585–92.CrossRefPubMed
13.
Zurück zum Zitat Grossman MP, Nakajima ST, Fallat ME, Siow Y. Müllerian-inhibiting substance inhibits cytochrome P450 aromatase activity in human granulosa lutein cell culture. Fertil Steril. 2008;89(5 Suppl):1364–70.CrossRefPubMed Grossman MP, Nakajima ST, Fallat ME, Siow Y. Müllerian-inhibiting substance inhibits cytochrome P450 aromatase activity in human granulosa lutein cell culture. Fertil Steril. 2008;89(5 Suppl):1364–70.CrossRefPubMed
14.
Zurück zum Zitat Hayes E, Kushnir V, Ma X, Biswas A, Prizant H, Gleicher N, et al. Intra-cellular mechanism of anti-Müllerian hormone (AMH) in regulation of follicular development. Mol Cell Endocrinol. 2016;433:56–65.CrossRefPubMed Hayes E, Kushnir V, Ma X, Biswas A, Prizant H, Gleicher N, et al. Intra-cellular mechanism of anti-Müllerian hormone (AMH) in regulation of follicular development. Mol Cell Endocrinol. 2016;433:56–65.CrossRefPubMed
15.
Zurück zum Zitat Pisarska MD, Bae J, Klein C, Hsueh AJW. Forkhead L2 is expressed in the ovary and represses the promoter activity of the steroidogenic acute regulatory gene. Endocrinology. 2004;145(7):3424–33.CrossRefPubMed Pisarska MD, Bae J, Klein C, Hsueh AJW. Forkhead L2 is expressed in the ovary and represses the promoter activity of the steroidogenic acute regulatory gene. Endocrinology. 2004;145(7):3424–33.CrossRefPubMed
16.
Zurück zum Zitat Kuo FT, Fan K, Bentsi-Barnes I, Barlow GM, Pisarska MD. Mouse forkhead L2 maintains repression of FSH-dependent genes in the granulosa cell. Reproduction. 2012;144(4):485–94.CrossRefPubMed Kuo FT, Fan K, Bentsi-Barnes I, Barlow GM, Pisarska MD. Mouse forkhead L2 maintains repression of FSH-dependent genes in the granulosa cell. Reproduction. 2012;144(4):485–94.CrossRefPubMed
17.
Zurück zum Zitat Park M, Suh DS, Lee K, Bae J. Positive cross talk between FOXL2 and anti-mullerian hormone regulates ovarian reserve. Fertil Steril. 2014;102(3):847–55.CrossRefPubMed Park M, Suh DS, Lee K, Bae J. Positive cross talk between FOXL2 and anti-mullerian hormone regulates ovarian reserve. Fertil Steril. 2014;102(3):847–55.CrossRefPubMed
18.
Zurück zum Zitat Uhlenhaut NH, Treier M. Forkhead transcription factors in ovarian function. Reproduction. 2011;142(4):489–95.CrossRefPubMed Uhlenhaut NH, Treier M. Forkhead transcription factors in ovarian function. Reproduction. 2011;142(4):489–95.CrossRefPubMed
19.
Zurück zum Zitat Hu S, Guo J, Wang B, Wang J, Zhou Z, Zhou G, et al. Genetic analysis of the FOXL2 gene using quantitative real-time PCR in Chinese patients with blepharophimosis-ptosis-epicanthus inversus syndrome. Mol Vis. 2011;17:436–42.PubMedPubMedCentral Hu S, Guo J, Wang B, Wang J, Zhou Z, Zhou G, et al. Genetic analysis of the FOXL2 gene using quantitative real-time PCR in Chinese patients with blepharophimosis-ptosis-epicanthus inversus syndrome. Mol Vis. 2011;17:436–42.PubMedPubMedCentral
20.
Zurück zum Zitat Park M, Shin E, Won M, Kim JH, Go H, Kim HL, et al. FOXL2 interacts with steroidogenic factor-1 (SF-1) and represses SF-1-induced CYP17 transcription in granulosa cells. Mol Endocrinol. 2010;24(5):1024–36.CrossRefPubMedPubMedCentral Park M, Shin E, Won M, Kim JH, Go H, Kim HL, et al. FOXL2 interacts with steroidogenic factor-1 (SF-1) and represses SF-1-induced CYP17 transcription in granulosa cells. Mol Endocrinol. 2010;24(5):1024–36.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Georges A, Auguste A, Bessière L, Vanet A, Todeschini AL, Veitia RA. FOXL2: a central transcription factor of the ovary. J Mol Endocrinol. 2013;52(1):R17–33.CrossRefPubMed Georges A, Auguste A, Bessière L, Vanet A, Todeschini AL, Veitia RA. FOXL2: a central transcription factor of the ovary. J Mol Endocrinol. 2013;52(1):R17–33.CrossRefPubMed
22.
Zurück zum Zitat Kedem A, Yung Y, Yerushalmi GM, Haas J, Maman E, Hanochi M, et al. Anti Müllerian hormone (AMH) level and expression in mural and cumulus cells in relation to age. J Ovarian Res. 2014;7:113.CrossRefPubMedPubMedCentral Kedem A, Yung Y, Yerushalmi GM, Haas J, Maman E, Hanochi M, et al. Anti Müllerian hormone (AMH) level and expression in mural and cumulus cells in relation to age. J Ovarian Res. 2014;7:113.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Prapa E, Vasilaki A, Dafopoulos K, Katsiani E, Georgoulias P, Messini CI, et al. Effect of anti-Müllerian hormone (AMH) and bone morphogenetic protein 15 (BMP-15) on steroidogenesis in primary-cultured human luteinizing granulosa cells through Smad5 signalling. J Assist Reprod Genet. 2015;32(7):1079–88.CrossRefPubMedPubMedCentral Prapa E, Vasilaki A, Dafopoulos K, Katsiani E, Georgoulias P, Messini CI, et al. Effect of anti-Müllerian hormone (AMH) and bone morphogenetic protein 15 (BMP-15) on steroidogenesis in primary-cultured human luteinizing granulosa cells through Smad5 signalling. J Assist Reprod Genet. 2015;32(7):1079–88.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Lee HJ, Jee BC, Kim SK, Kim H, Lee JR, Suh CS, et al. Expressions of aquaporin family in human luteinized granulosa cells and their correlations with IVF outcomes. Hum Reprod. 2016;31(4):822–31.CrossRefPubMed Lee HJ, Jee BC, Kim SK, Kim H, Lee JR, Suh CS, et al. Expressions of aquaporin family in human luteinized granulosa cells and their correlations with IVF outcomes. Hum Reprod. 2016;31(4):822–31.CrossRefPubMed
25.
Zurück zum Zitat Nordhoff V, Sonntag B, von Tils D, Gotte M, Schüring AN, Gromoll J, et al. Effects of the FSH receptor gene polymorphism p.N680S on cAMP and steroid production in cultured primary human granulosa cells. Reprod BioMed Online. 2011;23(2):196–203.CrossRefPubMed Nordhoff V, Sonntag B, von Tils D, Gotte M, Schüring AN, Gromoll J, et al. Effects of the FSH receptor gene polymorphism p.N680S on cAMP and steroid production in cultured primary human granulosa cells. Reprod BioMed Online. 2011;23(2):196–203.CrossRefPubMed
26.
Zurück zum Zitat Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCt method. Methods. 2001;25(4):402–8.CrossRefPubMed Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCt method. Methods. 2001;25(4):402–8.CrossRefPubMed
Metadaten
Titel
The anti-Müllerian hormone (AMH) induces forkhead box L2 (FOXL2) expression in primary culture of human granulosa cells in vitro
verfasst von
Sandro Sacchi
Federica Marinaro
Susanna Xella
Tiziana Marsella
Daniela Tagliasacchi
Antonio La Marca
Publikationsdatum
29.06.2017
Verlag
Springer US
Erschienen in
Journal of Assisted Reproduction and Genetics / Ausgabe 9/2017
Print ISSN: 1058-0468
Elektronische ISSN: 1573-7330
DOI
https://doi.org/10.1007/s10815-017-0980-9

Weitere Artikel der Ausgabe 9/2017

Journal of Assisted Reproduction and Genetics 9/2017 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.